Oral bioavailability and anti-simian varicella virus efficacy of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) in monkeys.

BV-araU (1-beta-D-arabinofuranosyl-E-5-[2-bromovinyl]uracil) has potent antiviral activity against varicella zoster virus in cell culture and is undergoing clinical evaluation. In the present study, pharmacokinetic parameters and the efficacy of BV-araU against infection with simian varicella virus (SVV) were evaluated in African green monkeys. Pharmacokinetic parameters were determined by analysis of the BV-araU content of sera obtained after oral and intravenous administration to normal monkeys. Peak serum concentrations showed dose proportionality, with the 0.1 mg/kg dose resulting in a peak serum concentration of 0.05 micrograms/ml, the approximately ED50 value for the SVV inoculum in cell culture. BV-araU administered orally twice daily at 0.1 mg/kg for 10 days starting 48 h after intratracheal SVV infection prevented vesicular rash development and suppressed viremia. Effective therapy could be initiated 96 h after infection. Taken together, these results indicate that BV-araU is effective oral therapy at doses that achieve peak serum levels equivalent to the ED50 for SVV in cell culture.
AuthorsK Soike, J L Huang, J I Tu, B Stouffer, J G Mitroka, M Swerdel, S Olsen, D P Bonner, A V Tuomari, A K Field
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 165 Issue 4 Pg. 732-6 (Apr 1992) ISSN: 0022-1899 [Print] UNITED STATES
PMID1313071 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Arabinofuranosyluracil
  • sorivudine
  • Administration, Oral
  • Adsorption
  • Animals
  • Antiviral Agents (administration & dosage, pharmacokinetics, pharmacology, therapeutic use)
  • Arabinofuranosyluracil (administration & dosage, analogs & derivatives, pharmacokinetics, pharmacology, therapeutic use)
  • Biological Availability
  • Cells, Cultured
  • Cercopithecus aethiops
  • Chickenpox (drug therapy)
  • Dose-Response Relationship, Drug
  • Female
  • Herpesvirus 3, Human (drug effects)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: